SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+3.92%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$392M
AUM Growth
+$392M
(+3.6%)
Cap. Flow
+$10.5K
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
64.87%
Holding
28
New
2
Increased
13
Reduced
8
Closed
4
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$28M |
| 2 |
Owens & Minor
OMI
|
$7.97M |
| 3 |
Baxter International
BAX
|
$5.03M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$4.61M |
| 5 |
MDCO
Medicines Co
MDCO
|
$3.55M |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
$15.7M |
| 2 |
Quest Diagnostics
DGX
|
$8.81M |
| 3 |
LPNT
LifePoint Health, Inc.
LPNT
|
$8.79M |
| 4 |
Eli Lilly
LLY
|
$7.7M |
| 5 |
Boston Scientific
BSX
|
$6.26M |
Sector Composition
| 1 | Healthcare | 89.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $49.9M | 12.74% | 713,500 +72,000 | +11% | +$5.03M |
|
|
2
Eli Lilly
LLY
$657B
| $31.2M | 7.98% | 374,247 -92,200 | -20% | -$7.7M |
|
|
3
Boston Scientific
BSX
$156B
| $31.2M | 7.97% | 1,764,000 -353,600 | -17% | -$6.26M |
|
|
4
Johnson & Johnson
JNJ
$427B
| $28M | 7.16% | +287,800 | New | +$28M |
|
5
Stryker
SYK
$150B
| $25M | 6.38% | 261,483 +12,600 | +5% | +$1.2M |
|
6
Revvity
RVTY
$10.5B
| $18.7M | 4.77% | 355,060 -65,200 | -16% | -$3.43M |
|
7
Bristol-Myers Squibb
BMY
$96B
| $18.6M | 4.75% | 279,400 +3,500 | +1% | +$233K |
|
8
Cardinal Health
CAH
$35.5B
| $17.5M | 4.47% | 209,400 +9,600 | +5% | +$803K |
|
9
Tenet Healthcare
THC
$16.3B
| $17M | 4.33% | 293,000 +31,500 | +12% | +$1.82M |
|
10
Ironwood Pharmaceuticals
IRWD
$214M
| $16.9M | 4.32% | 1,402,891 +240,700 | +21% | +$2.9M |
|
11
Bio-Rad Laboratories Class A
BIO
$8.06B
| $15.9M | 4.05% | 105,400 +13,000 | +14% | +$1.96M |
|
|
12
Teva Pharmaceuticals
TEVA
$21.1B
| $15.5M | 3.95% | 262,000 +78,000 | +42% | +$4.61M |
|
|
MDCO
13
DELISTED
Medicines Co
MDCO
| $12.9M | 3.29% | 450,750 +124,100 | +38% | +$3.55M |
|
14
Integra LifeSciences
IART
$1.18B
| $12.7M | 3.25% | 189,063 +4,100 | +2% | +$276K |
|
15
Cigna
CI
$80.3B
| $11.8M | 3.02% | 73,000 -22,200 | -23% | -$3.6M |
|
16
Masimo
MASI
$7.59B
| $10.6M | 2.7% | 272,623 +8,200 | +3% | +$318K |
|
|
THOR
17
DELISTED
THORATEC CORPORATION
THOR
| $10.2M | 2.61% | 229,300 -20,200 | -8% | -$900K |
|
18
Community Health Systems
CYH
$387M
| $10.1M | 2.57% | 159,900 +46,100 | +41% | +$2.9M |
|
19
Vertex Pharmaceuticals
VRTX
$100B
| $9.07M | 2.32% | 73,463 -1,000 | -1% | -$123K |
|
|
RAD
20
DELISTED
Rite Aid Corporation
RAD
| $8.87M | 2.27% | 1,062,800 +286,800 | +37% | +$2.39M |
|
|
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
| $8.35M | 2.13% | 98,445 -32,100 | -25% | -$2.72M |
|
|
22
Owens & Minor
OMI
$378M
| $7.97M | 2.03% | +234,252 | New | +$7.97M |
|
|
MNTA
23
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.2M | 0.82% | 140,440 -34,660 | -20% | -$790K |
|
|
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $475K | 0.12% | 69,500 | – | – |
|
25
Cencora
COR
$56.5B
| – | – | -45,300 | Closed | -$5.15M |
|